TBXT is a transcription factor encoded by the TBXT gene, crucial for:
Embryogenesis: Directing mesoderm specification and notochord development during gastrulation .
Cancer Biology: Acting as a driver in chordoma (a rare spinal cancer) and promoting epithelial-mesenchymal transition (EMT) in breast cancer .
Regulatory Functions: Modulating gene networks involved in cell cycle control, DNA repair, and metabolic processes .
TBXT antibodies are widely used in research for:
Chordoma: TBXT is overexpressed in >90% of chordomas and sustains tumor cell survival. Antibodies helped identify TBXT-DNA interactions and fragment-based inhibitors .
Breast Cancer: TBXT drives EMT and metastasis. Antibody-based assays revealed miR-219-5p suppresses TBXT, reducing invasion and stemness .
Therapeutic Targeting: DARPins (designed ankyrin repeat proteins) blocking TBXT-DNA binding inhibit tumor growth in preclinical models .
TBXT dosage controls EMT timing during gastrulation. Heterozygous (TBXT-Het) models show delayed EMT, highlighting its role in cell adhesion and migration .
Specificity: Polyclonal antibodies (e.g., Proteintech 20741-1-AP) target epitopes in the C-terminal region (residues 226-435) .
Limitations: Commercial antibodies may exhibit cross-reactivity with paralogs (e.g., TBX6). Knockout validation is recommended .